PD-L1 is expressed by tumor cells and immunosuppressive immune cell populations, such as tumor-associated macrophages (TAMs) and myeloid-derived suppressor cells (MDSCs); PD-L1 inhibits T cell activation by binding to PD-1 expressed by T cells [55]. The gene discussed is CD274; the disease is neoplasm.